La Jolla Pharmaceutical (LJPC) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Corporate Presentation Developing Innovative Therapies for Patients Suffering from Life-threatening Diseases NASDAQ: LJPC January 2019 Forward-Looking Statements These slides contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements related to La Jolla's expectations regarding net sales and net cash used in operating activities for the full-year 2019, the expectation for future clinical and regulatory milesto ...